BioNTech SE (BVMF:B1NT34)
32.33
-1.92 (-5.61%)
At close: Apr 28, 2026
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of 128.51 billion as of April 30, 2026. Its market cap has decreased by -5.79% in one year.
Market Cap
128.51B
Enterprise Value
49.36B
Revenue
18.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
32.33
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from 12.31B to 128.51B, an increase of 943.81%. That is a compound annual growth rate of 43.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 129.10B | 2.39% |
| Dec 31, 2025 | 126.09B | -25.38% |
| Dec 31, 2024 | 168.96B | 38.79% |
| Dec 29, 2023 | 121.74B | -36.92% |
| Dec 30, 2022 | 192.99B | -44.37% |
| Dec 31, 2021 | 346.92B | 240.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 84.79B |
| Raia Drogasil | 38.53B |
| Hypera | 13.93B |
| Fleury | 8.68B |
| Odontoprev | 7.95B |
| Diagnósticos da América | 4.00B |
| Empreendimentos Pague Menos | 3.65B |
| Blau Farmacêutica | 2.32B |